Stains & CD markers
Estrogen receptor


Last author update: 1 June 2005
Last staff update: 16 April 2024 (update in progress)

Copyright: 2002-2024, PathologyOutlines.com, Inc.

PubMed Search: Estrogen receptor

Nat Pernick, M.D.
Page views in 2023: 15,703
Page views in 2024 to date: 6,109
Cite this page: Pernick N. Estrogen receptor. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/stainser.html. Accessed May 19th, 2024.
Definition / general
  • See also Breast malignant topic
  • 2 subtypes: ER alpha and ER beta
  • ER alpha:
    • Classic functions of ER
    • May render breast epithelium susceptible to proliferative stimulation of estrogen
    • Expressed in breast and endometrium
  • ER beta:
    • Housekeeping functions
    • Expressed in normal ovary and granulosa cells
    • Carcinoma of breast, colon, prostate
  • Both alpha and beta share highly conserved DNA binding domain and commonly interact with estrogen-regulating factors, but may affect different genes
  • Presence of estrogen (type alpha) and progesterone receptors correlates best with response to anti-estrogen treatment (tamoxifen or others) or chemotherapy, only weakly with prognosis
    • Presence is associated with better differentiated tumors, older age
  • Evaluate percentage of tumor nuclei stained and intensity of staining (none, weak, moderate, strong)
  • Immunostaining now done on paraffin fixed tissue (previously required fresh tissue)
  • Metastases to skin are often positive for androgen receptor, even if ER-, PR- (Mod Pathol 2000;13:119)
  • Antigen retrieval techniques are required for ER if glyoxal fixative is used (Hum Pathol 2004;35:1058)
  • Compared to ER, PR staining adds only a limited amount of additional predictive information for response to hormonal therapy (Mod Pathol 2004;17:1545)
Interpretation
Uses by pathologists
  • In breast cancer, predicts response to tamoxifen or other anti-estrogens
    • Also prognostic marker for survival (ER+ is favorable)
  • Relatively specific for breast origin (but numerous exceptions)
  • Distinguishes endocervical (ER-) from endometrial (ER+) adenocarcinomas (Am J Surg Pathol 2002;26:998)
Microscopic (histologic) images

Contributed by Jijgee Munkhdelger, M.D., Ph.D., Andrey Bychkov, M.D., Ph.D. and Leica Microsystems

Breast, mucinous carcinoma

Missing Image

Breast tubular adenoma immunoprofile

Missing Image

Invasive ductal carcinoma, intense nuclear staining

Positive staining - disease
  • Breast carcinoma (varies by subtype and tumor grade) - well differentiated tumors are typically positive
  • Endometrial adenocarcinoma (75%)
  • Ovarian serous, mucinous and endometrioid adenocarcinoma (Am J Surg Pathol 2001;25:667), papillary urothelial carcinoma of bladder (10 - 20%) and ovarian transitional cell carcinoma (90%, Arch Pathol Lab Med 2005;129:194)
Negative staining
  • Endocervical adenocarcinoma, ovarian clear cell carcinoma
Back to top
Image 01 Image 02